You just read:

Study findings show nintedanib* slows progression of Idiopathic Pulmonary Fibrosis (IPF), a debilitating and fatal lung disease

News provided by

Boehringer Ingelheim (Canada) Ltd.

May 20, 2014, 07:59 ET